{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:36:22Z","timestamp":1789054582323,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS17\/01463"],"award-info":[{"award-number":["FIS17\/01463"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS17\/01463"],"award-info":[{"award-number":["FIS17\/01463"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"DOI":"10.1186\/s41479-025-00163-1","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T23:02:29Z","timestamp":1746399749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilation"],"prefix":"10.1186","volume":"17","author":[{"given":"Loreto","family":"Vidaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalur","family":"Guridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oihana","family":"Leizaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jokin","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sarasqueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Sorarrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Marim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"163_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1378\/chest.13-1531","volume":"146","author":"S Gattarello","year":"2014","unstructured":"Gattarello S, Borgatta B, Sol\u00e9-Viol\u00e1n J, Vall\u00e9s J, Vidaur L, Zaragoza R, et al. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000\u20132013). Chest. 2014;146:22\u201331.","journal-title":"Chest"},{"key":"163_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/MCC.0000000000001083","volume":"29","author":"A Ruiz-Spinelli","year":"2023","unstructured":"Ruiz-Spinelli A, Waterer G, Rello J. Severe community-acquired pneumonia in the post COVID-19 era. Curr Opin Crit Care. 2023;29:400\u20136.","journal-title":"Curr Opin Crit Care"},{"key":"163_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1586\/ers.13.24","volume":"7","author":"RP Dickson","year":"2013","unstructured":"Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013;7:245\u201357.","journal-title":"Expert Rev Respir Med"},{"key":"163_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4037\/ajcc2021194","volume":"30","author":"ML Sole","year":"2021","unstructured":"Sole ML, Yooseph S, Talbert S, Abomoelak B, Deb C, Rathbun KP, et al. Pulmonary Microbiome of Patients Receiving Mechanical Ventilation: Changes Over Time. Am J Crit Care. 2021;30:128\u201332.","journal-title":"Am J Crit Care"},{"key":"163_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1165\/rcmb.2019-0273TR","volume":"62","author":"SM Carney","year":"2020","unstructured":"Carney SM, Clemente JC, Cox MJ, Dickson RP, Huang YJ, Kitsios GD, et al. Methods in Lung Microbiome Research. Am J Respir Cell Mol Biol. 2020;62:283\u201399.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"163_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132253","volume":"10","author":"G Yu","year":"2015","unstructured":"Yu G, Fadrosh D, Goedert JJ, Ravel J, Goldstein AM. Nested PCR Biases in Interpreting Microbial Community Structure in 16S rRNA Gene Sequence Datasets. PLoS ONE. 2015;10: e0132253.","journal-title":"PLoS ONE"},{"key":"163_CR7","doi-asserted-by":"publisher","first-page":"17724","DOI":"10.1038\/s41598-023-45007-4","volume":"13","author":"JM Marim\u00f3n","year":"2023","unstructured":"Marim\u00f3n JM, Sorarrain A, Ercibengoa M, Azcue N, Alonso M, Vidaur L. Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia. Sci Rep. 2023;13:17724.","journal-title":"Sci Rep"},{"key":"163_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41579-022-00821-x","volume":"21","author":"JG Natalini","year":"2023","unstructured":"Natalini JG, Singh S, Segal LN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol. 2023;21:222\u201335.","journal-title":"Nat Rev Microbiol"},{"key":"163_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1164\/rccm.201104-0655OC","volume":"184","author":"ES Charlson","year":"2011","unstructured":"Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184:957\u201363.","journal-title":"Am J Respir Crit Care Med"},{"key":"163_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11684-021-0856-3","volume":"16","author":"S Du","year":"2022","unstructured":"Du S, Wu X, Li B, Wang Y, Shang L, Huang X, et al. Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia. Front Med. 2022;16:389\u2013402.","journal-title":"Front Med"},{"key":"163_CR11","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1080\/21655979.2021.1997563","volume":"12","author":"L Hong","year":"2021","unstructured":"Hong L, Chen Y, Ye L. Characteristics of the lung microbiota in lower respiratory tract infections with and without history of pneumonia. Bioengineered. 2021;12:10480\u201390.","journal-title":"Bioengineered"},{"key":"163_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020;324:1307\u201316.","journal-title":"JAMA"},{"issue":"Pt 1","key":"163_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1099\/00221287-148-1-257","volume":"148","author":"MA Nadkarni","year":"2002","unstructured":"Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology (Reading). 2002;148(Pt 1):257\u201366.","journal-title":"Microbiology (Reading)"},{"key":"163_CR14","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1164\/rccm.201806-1135OC","volume":"199","author":"FS Leitao Filho","year":"2019","unstructured":"Leitao Filho FS, Alotaibi NM, Ngan D, Tam S, Yang J, Hollander Z, et al. Sputum microbiome is associated with 1-year mortality after chronic obstructive pulmonary disease hospitalizations. Am J Respir Crit Care Med. 2019;199:1205\u201313.","journal-title":"Am J Respir Crit Care Med"},{"key":"163_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nri3769","volume":"14","author":"BJ Marsland","year":"2014","unstructured":"Marsland BJ, Gollwitzer ES. Host-microorganism interactions in lung diseases. Nat Rev Immunol. 2014;14:827\u201335.","journal-title":"Nat Rev Immunol"},{"key":"163_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1164\/rccm.201907-1487OC","volume":"201","author":"RP Dickson","year":"2020","unstructured":"Dickson RP, Schultz MJ, van der Poll T, Schouten LR, Falkowski NR, Luth JE, et al. Lung microbiota predict clinical outcomes in critically ill patients. Am J Respir Crit Care Med. 2020;201:555\u201363.","journal-title":"Am J Respir Crit Care Med"},{"key":"163_CR17","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/nmicrobiol.2016.31","volume":"1","author":"LN Segal","year":"2016","unstructured":"Segal LN, Clemente JC, Tsay JCJ, Koralov SB, Keller BC, Wu BG, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. 2016;1:16031.","journal-title":"Nat Microbiol"},{"key":"163_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QCO.0000000000000977","volume":"36","author":"D Koulenti","year":"2023","unstructured":"Koulenti D, Vandana KE, Rello J. Current viewpoint on the epidemiology of nonfermenting gram-negative bacterial strains. Curr Opin Infect Dis. 2023;36:545\u201354.","journal-title":"Curr Opin Infect Dis"},{"key":"163_CR19","first-page":"405","volume":"81","author":"G Dimopoulos","year":"2015","unstructured":"Dimopoulos G, Koulenti D, Tabah A, Poulakou G, Vesin A, Arvaniti K, et al. Bloodstream infections in ICU with increased resistance: epidemiology and outcomes. Minerva Anestesiol. 2015;81:405\u201318.","journal-title":"Minerva Anestesiol"},{"key":"163_CR20","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1038\/s41591-023-02617-9","volume":"29","author":"E Montassier","year":"2023","unstructured":"Montassier E, Kitsios GD, Radder JE, Le Bastard Q, Kelly BJ, Panzer A, Lynch SV, Calfee CS, Dickson RP, Roquilly A. Robust airway microbiome signatures in acute respiratory failure and hospital-acquired pneumonia. Nat Med. 2023;29:2793\u2013804.","journal-title":"Nat Med"},{"key":"163_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101167","volume":"4","author":"AE P\u00e9rez-Cobas","year":"2023","unstructured":"P\u00e9rez-Cobas AE, Ginevra C, Rusniok C, Jarraud S, Buchrieser C. The respiratory tract microbiome, the pathogen load, and clinical interventions define severity of bacterial pneumonia. Cell Rep Med. 2023;4: 101167.","journal-title":"Cell Rep Med"},{"key":"163_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2012.04.009","volume":"65","author":"C Cill\u00f3niz","year":"2012","unstructured":"Cill\u00f3niz C, Ewig S, Men\u00e9ndez R, Ferrer M, Polverino E, Reyes S, et al. Bacterial coinfection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect. 2012;65:223\u201330.","journal-title":"J Infect"},{"key":"163_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1378\/chest.10-1396","volume":"139","author":"I Mart\u00edn-Loeches","year":"2011","unstructured":"Mart\u00edn-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R, Villavicencio C, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139:555\u201362.","journal-title":"Chest"},{"key":"163_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0041-1740606","volume":"43","author":"A Bourdiol","year":"2022","unstructured":"Bourdiol A, Roquilly A. new insights in the pathophysiology of hospital- and ventilator-acquired pneumonia: a complex interplay between dysbiosis and critical-illness-related immunosuppression. Semin Respir Crit Care Med. 2022;43:271\u20139.","journal-title":"Semin Respir Crit Care Med"},{"key":"163_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","volume":"5","author":"HFL Wertheim","year":"2005","unstructured":"Wertheim HFL, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751\u201362.","journal-title":"Lancet Infect Dis"},{"key":"163_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","volume":"4","author":"D Bogaert","year":"2004","unstructured":"Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144\u201354.","journal-title":"Lancet Infect Dis"},{"key":"163_CR27","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1128\/IAI.00789-06","volume":"74","author":"LA McNamee","year":"2006","unstructured":"McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun. 2006;74:6707\u201321.","journal-title":"Infect Immun"},{"key":"163_CR28","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4049\/jimmunol.1300014","volume":"191","author":"HE Ghoneim","year":"2013","unstructured":"Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol. 2013;191:1250\u20139.","journal-title":"J Immunol"},{"key":"163_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12941-023-00626-7","volume":"22","author":"\u00c1 Estella","year":"2023","unstructured":"Estella \u00c1, Mart\u00edn-Loeches I, N\u00fa\u00f1ez MR, Garc\u00eda CG, Pesaresi LM, Escors AA. et al Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study. Ann Clin Microbiol Antimicrob. 2023;22:90.","journal-title":"Ann Clin Microbiol Antimicrob."},{"key":"163_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2024.102428","volume":"77","author":"ZG Drigot","year":"2024","unstructured":"Drigot ZG, Clark SE. Insights into the role of the respiratory tract microbiome in defense against bacterial pneumonia. Curr Opin Microbiol. 2024;77: 102428.","journal-title":"Curr Opin Microbiol"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-025-00163-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-025-00163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T23:02:30Z","timestamp":1746399750000},"score":1,"resource":{"primary":{"URL":"https:\/\/pneumonia.biomedcentral.com\/articles\/10.1186\/s41479-025-00163-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["163"],"URL":"https:\/\/doi.org\/10.1186\/s41479-025-00163-1","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the regional (Gipuzkoa) Ethics Committee, reference MOZ-NBI-2017\u201301. Written informed consent was given by patients or their legal representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JR received consulting fees\/speaking bureau from Merck, Pfizer and Roche. All the rest of the authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}